Mitsubishi UFJ Asset Management Co. Ltd. Purchases 9,960 Shares of Humana Inc. $HUM

Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Humana Inc. (NYSE:HUM) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,330 shares of the insurance provider’s stock after acquiring an additional 9,960 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Humana were worth $66,207,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Montag A & Associates Inc. raised its holdings in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC raised its holdings in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton raised its holdings in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares in the last quarter. Mather Group LLC. bought a new stake in shares of Humana in the third quarter valued at about $34,000. Finally, Larson Financial Group LLC raised its holdings in shares of Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Morgan Stanley set a $146.00 target price on Humana in a research note on Thursday, February 12th. Royal Bank Of Canada lifted their target price on Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research note on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and issued a $260.00 target price on shares of Humana in a research note on Thursday, April 30th. The Goldman Sachs Group lifted their target price on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Finally, JPMorgan Chase & Co. lifted their target price on Humana from $180.00 to $214.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Seven equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $247.61.

Insider Buying and Selling

In other news, insider Sanjay K. Shetty bought 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the transaction, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.20% of the stock is currently owned by corporate insiders.

Humana Stock Performance

HUM opened at $247.28 on Friday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.35. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a market cap of $29.69 billion, a P/E ratio of 26.45, a price-to-earnings-growth ratio of 2.27 and a beta of 0.68. The firm’s 50-day moving average price is $192.18 and its 200-day moving average price is $226.48.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter in the prior year, the company posted $11.58 earnings per share. The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts anticipate that Humana Inc. will post 9.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. Humana’s dividend payout ratio is currently 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.